How long do you take Zytiga for?
Zytiga (abiraterone acetate) is a hormone therapy taken in combination with prednisone to treat prostate cancer that has already spread (metastasized) to other parts of the body.
Patients typically take medications such as Zytiga for as long as they are effective for or as long as they can tolerate them. Adverse effects including hepatotoxicity (liver toxicity) or cardiac disorders, for example, can result in patients needing to stop treatment.
The length of time patients remain on Zytiga varies. The median amount of time patients with metastatic prostate cancer remained on Zytiga ranged from 8 to 24 months, according to the results from clinical trials used to gain Food and Drug Administration (FDA) approval for Zytiga in the US.
Results from one clinical trial also showed that patients with metastatic prostate cancer who had not received prior cytotoxic chemotherapy remained on Zytiga for a median of 25.2 months until they needed to start taking cytotoxic chemotherapy.
Your doctor will monitor your health to see if you should continue taking Zytiga
Your doctor will monitor your health while you are on Zytiga to check to see if it is working for you and isn’t causing any side effects of concern.
Your doctor will likely:
Related medical questions
- How long do you take Zytiga for?
- Xtandi vs Zytiga: How do they compare?
- Is Zytiga a form of chemotherapy?
- Why is prednisone prescribed with Zytiga?
- What does abiraterone therapy do?
- How long do you take Zytiga for?
- Xtandi vs Zytiga: How do they compare?
- Is Zytiga a form of chemotherapy?
- Why is prednisone prescribed with Zytiga?
- What does abiraterone therapy do?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions